Diverse modulating effects of estradiol and progesterone on the monophasic action potential duration in Langendorff-perfused female rabbit hearts

Fundamental and Clinical Pharmacology

Volumn 26, Issue 2, 2012, Pages 219-226

  Cheng, Jianhua ^a   Ma, Xiaohong ^b   Zhang, Juan ^a   Su, Dan ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Weinan First People's Hospital   (China)

Author keywords

Anti arrhythmic agents; Estradiol; Monophasic action potential; Progesterone; Repolarization

Indexed keywords

ESTRADIOL; POTASSIUM CHANNEL; PROGESTERONE; SOTALOL;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SENSITIVITY; EXPERIMENTAL RABBIT; FEMALE; HEART ARRHYTHMIA; HEART DEPOLARIZATION; HEART PROTECTION; HEART REPOLARIZATION; INCIDENCE; ISOLATED HEART; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ACTION POTENTIALS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ARRHYTHMIAS, CARDIAC; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; PERICARDIUM; PROGESTERONE; RABBITS; SEX FACTORS; SOTALOL;

EID: 84863230314     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2010.00911.x     Document Type: Article

References (24)

1. James A.F., Choisy S.C.M., Hancox J.C. Recent advances in understanding sex differences in cardiac repolarization. Prog. Biophys. Mol. Biol. (2007) 94 265-319.
2. Cheng J. Evidences of the gender-related differences in cardiac repolarization and the underlying mechanisms in different animal species and human. Fundam. Clin. Pharmacol. (2006) 20 1-8.
3. Imboden M., Swan H., Denjoy I. et al. Female predominance and transmission distortion in the long-QT syndrome. N. Engl. J. Med. (2006) 355 2744-2751.
4. Nakagawa M., Ooie T., Takahashi N. et al. Influence of menstrual cycle on QT interval dynamics. Pacing Clin. Electrophysiol. (2006) 29 607-613.
5. Burke J.H., Ehlert F.A., Kruse J.T., Parker M.A., Goldberger J.J., Kadish A.H. Gender-specific difference in the QT interval and the effects of autonomic tone and menstrual cycle in healthy adults. Am. J. Cardiol. (1997) 79 178-181.
6. Rodriguez I., Kilborn M.J., Liu X.K., Pezzullo J.C., Woosley R.L. Drug-induced QT prolongation in women during the menstrual cycle. JAMA (2001) 285 1322-1326.
7. Marchlonski F.E., Deely M.P., Zado E.S. Sex-specific triggers for right ventricular outflow tract tachycardia. Am. Heart J. (2000) 139 1009-1013.
8. Nakazato Y., Nakata Y., Takano T. et al. Long-term follow-up study of three patients with the long QT syndrome. Jpn. Circ. J. (1992) 56 1025-1031.
9. Rashba E.J., Zareba W., Moss A.J. et al. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. Circulation (1998) 97 451-456.
10. Zhou J.T., Zheng L.R., Liu W.Y. Role of early afterdepolarization in familial long QTU syndrome and torsades de pointes. Pacing Clin. Electrophysiol. (1992) 2 2164-2168.
11. Tanabe S., Hata T., Hiraoka M. Effects of estrogen on action potential and membrane currents in guinea pig ventricular myocytes. Am. J. Physiol. (1999) 277 H826-H833.
12. Berger F., Borchard U., Hafner D., Putz I., Weis T.M. Effects of 17β-estradiol on action potentials and ionic currents in male rat ventricular myocytes. Naunyn Schmiedebergs Arch. Pharmacol. (1997) 356 788-796.
13. Nakajima T., Iwasawa K., Oonuma H. et al. Antiarrhythmic effect and its underlying ionic mechanisms of 17β-estradiol in cardiac myocytes. Br. J. Pharmacol. (1999) 127 429-440.
14. Kr channels and drug-induced prolongation of cardiac repolarization. J. Physiol. (2008) 586 2961-2973.
15. James A.F., Arberry L.A., Hancox J.C. Gender-related differences in ventricular myocyte repolarization in the guinea pig. Basic Res. Cardiol. (2004) 99 183-192.
16. K-blocking drugs. Circulation (2001) 103 2207-2212.
17. Hara M., Danilo P. Jr, Rosen M.R. Effects of gonadal steroids on ventricular repolarization and on the response to E-4031. J. Pharmacol. Exp. Ther. (1998) 285 1068-1072.
18. Drici M.D., Burklow T.R., Haridasse V., Glazer R.I., Woosley R.L. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation (1996) 94 1471-1474.
19. Drici M.D., Knollmann B.C., Wang W.X., Woosley R.L. Cardiac actions of erythromycin: influence of female sex. JAMA (1998) 280 1774-1776.
20. Lehmann M.H., Hardy S., Archibald D., Quart B., MacNeil D.J. Sex difference in risk of torsade de pointes with d, l-sotalol. Circulation (1996) 94 2535-2541.
21. Makkar R.R., Fromm B.S., Steinman R.T., Meissner M.D., Lehmann M.H. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA (1993) 270 2590-2597.
22. Nakamura H., Kurokawa J., Bai C.X. et al. Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study. Circulation (2007) 116 2913-2922.
23. Dhote V.V., Balaraman R. Gender specific effect of progesterone on myocardial ischemia/reperfusion injury in rats. Life Sci. (2007) 81 188-197.
24. Kuwabara Y. Outpatient clinic in obstetrics and gynecology, 1st edn, Medical view, Tokyo, Japan, 1996.